Currently out of the existing stock ratings of Mitchell Kapoor, 221 are a BUY (88.4%), 21 are a HOLD (8.4%), 8 are a SELL (3.2%).

Mitchell Kapoor

Work Performance Price Targets & Ratings Chart

Analyst Mitchell Kapoor, carries an average stock price target met ratio of 35.96% that have a potential upside of 30.55% achieved within 56 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.

Mitchell Kapoor’s has documented 492 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TIL, Instil Bio at 05-Jun-2025.

Wall Street Analyst Mitchell Kapoor

Analyst best performing recommendations are on SMMT (SUMMIT THERAPEUTICS PLC).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.

Average potential price target upside

IMGO Imago Biosciences IPSC Century Therapeutics LEGN Legend Biotech Corp LYEL Lyell Immunopharma RAIN Rain Therapeutics RANI Rani Therapeutics Holdings TYRA Tyra Biosciences HALO Halozyme Therapeutics RLYB Rallybio Corp RPHM Reneo Pharmaceuticals TIL Instil Bio CRSP Crispr Therapeutics AG SRPT Sarepta Therapeutics VERV Verve Therapeutics CTMX CytomX Therapeutics ALMS Alumis Common Stock KRRO Frequency Therapeutics KYTX Kyverna Therapeutics, Common Stock LXEO Lexeo Therapeutics, Common Stock MGX Metagenomi, Common Stock NGNE Neurogene ORKA Oruka Therapeutics RNAC Cartesian Therapeutics SMMT Summit Therapeutics PLC TCBP TC BioPharm Holdings PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$36

$-0.01 (-0.03%)

$36

2 years 6 months 23 days ago
(28-Nov-2022)

3/3 (100%)

$0.35 (0.98%)

267

Hold

$36

$-0.01 (-0.03%)

$35

2 years 6 months 29 days ago
(22-Nov-2022)

3/4 (75%)

$0.4 (1.12%)

145

Hold

$36

$-0.01 (-0.03%)

2 years 6 months 29 days ago
(22-Nov-2022)

1/1 (100%)

$0.4 (1.12%)

48

Hold

$36

$-0.01 (-0.03%)

$30

2 years 6 months 29 days ago
(22-Nov-2022)

2/2 (100%)

$0.4 (1.12%)

258

Hold

$36

$-0.01 (-0.03%)

$25

2 years 6 months 30 days ago
(21-Nov-2022)

2/2 (100%)

$0.41 (1.15%)

37

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mitchell Kapoor is most bullish on?

Potential upside of $90.77 has been obtained for TIL (INSTIL BIO)

Which stock is Mitchell Kapoor is most reserved on?

Potential downside of -$8.74 has been obtained for LYEL (LYELL IMMUNOPHARMA)

What Year was the first public recommendation made by Mitchell Kapoor?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?